monocrotaline has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Han, H; He, M; Kong, H; Li, X; Wang, H; Wang, J; Wei, G; Xie, W; Xu, J; Zhu, J; Zuo, X | 1 |
| Furuichi, K; Iwata, Y; Kaneko, S; Sakai, Y; Shimizu, M; Wada, T; Yokoyama, H | 1 |
1 review(s) available for monocrotaline and Chronic Kidney Diseases
| Article | Year |
|---|---|
Nodular lesions and mesangiolysis in diabetic nephropathy.
Topics: Animals; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Endothelial Cells; Extracellular Matrix; Glomerular Mesangium; Humans; Kidney; Monocrotaline; Renal Insufficiency, Chronic | 2013 |
1 other study(ies) available for monocrotaline and Chronic Kidney Diseases
| Article | Year |
|---|---|
Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
Topics: Animals; Dipeptidyl-Peptidase IV Inhibitors; Fibrosis; Glomerular Mesangium; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Microcirculation; Monocrotaline; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sitagliptin Phosphate | 2018 |